JENBURKT PHARMACEUTICALS LTD. Share Price

Jenburkt Pharmaceuticals Limited is an India-based company that is engaged in the business of manufacturing, producing, developing and marketing a range of branded pharmaceuticals and healthcare products. The Company offers pharmaceutical products for various therapeutic areas, including analgesic and antipyretics, anthelmintics, anti-arthritics, anti-diabetics, anti-infectives, antifungals, antimalarials, antiulcerants/antacids, aphrodisiac, consumer products, muscle relaxants, neuropathic pain, nutraceuticals, and pain management. The Company's product brands include Allerzine tablets, Cartisafe forte MSM tablets, Eberjen Cream and SOL, ECOPROT powder, Frendacid suspension, Fundu tablets, Glajen-E capsules, GLUCOTROL tablets, Jenflam tablets, Lutriben cream, Ornel tablets, Pantazole tablets, Topcal-M Tablets, Powergesic, ZIX P Tablet, and others. The Company's manufacturing plant is in Sihor, Gujarat. As of 26 May 2026, JENBURKT PHARMACEUTICALS LTD. share price is ₹1,166.20. The stock opened at ₹1,166.60, compared to its previous close of ₹1,154.70. During today's trading session, JENBURKT PHARMACEUTICALS LTD. share price moved in the range of ₹1,134.40 to ₹1,174.90, with an average price of ₹1,154.65 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,134.40 and a high of ₹1,174.90.

The market capitalization of JENBURKT PHARMACEUTICALS LTD. is ₹510 Crs, with a P/E ratio of 14.7 and a dividend yield of 1.79%.